Novel Study Demonstrates Role of Parkin Gene in Eye Lens
A new study at ÑDz©¹ÙÍø is the first to demonstrate that the Parkin gene is turned on when cells are exposed to environmental insults that cause free radical formation and cataract formation.
Hispanics Think Trump Will Not Be Good for U.S. Economy
A majority of Hispanics think U.S. President-elect Donald Trump will not be good for the country's economy or the United States' relationships with other countries, according to a new ÑDz©¹ÙÍø national poll.
ÑDz©¹ÙÍø Jupiter's LLS Announces 'Opening Week'
ÑDz©¹ÙÍø's Lifelong Learning Society Jupiter has announced its lecture and performance offerings for the "2016 Opening Week," which begins Tuesday, Jan. 3, 2017.
Study Shows How Social Media Sites Help Transplant Patients
Researchers in ÑDz©¹ÙÍø's Christine E. Lynn College of Nursing conducted a unique study to explore how transplant recipients use social media sites for support and healing.
Venture Investment Beats Bank Loans to Boost Small Business
Investment from venture capital appears to help new startup businesses grow and boost entrepreneurship better than funding from bank loans, according to a ÑDz©¹ÙÍø new study.
Janet Robishaw to Lead Department of Biomedical Sciences
Janet Robishaw, Ph.D., a leader in functional and translational genomics, has been appointed as chair of the Department of Biomedical Sciences in ÑDz©¹ÙÍø's Charles E. Schmidt College of Medicine.
ÑDz©¹ÙÍø Student Government Honors its Very First President
In 1965, just one year after ÑDz©¹ÙÍø opened its doors, Daniel Mica, BA '66, became the University's very first Student Government (SG) president.
ÑDz©¹ÙÍø Brain Institute Designated 'Nikon Center Of Excellence'
ÑDz©¹ÙÍø's Brain Institute in Jupiter is now home to a Nikon Center of Excellence.
Having Former Politicians on Board Helps Complete Mergers
Study finds appointing former politicians and regulators to boards of directors or management teams influences corporate mergers and acquisitions and improves the financial performance of acquiring companies.
ÑDz©¹ÙÍø and Neuro Pharmalogics Enter into Licensing Agreement
ÑDz©¹ÙÍø has entered into a licensing agreement with Neuro Pharmalogics, Inc., a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare neurological diseases.